IE
VIR icon

Israel Englander’s Vir Biotechnology VIR Stock Holding History

Israel Englander’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-100,000
Closed -$2.68M – 6544
2020
Q4 		$2.68M Buy
+100,000
New +$3.25M ﹤0.01% 2994
2020
Q3 		– Sell
-30,000
Closed -$1.23M – 4849
2020
Q2 		$1.23M Buy
+30,000
New +$1.01M ﹤0.01% 2871

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Israel Englander's VIR Position: Q2 2026 in Review

Israel Englander reduced its Vir Biotechnology (VIR) stake by 90% in Q2 2026, selling an estimated $4.2M and leaving 47,993 shares worth $489K. The position accounts for ﹤0.01% of the portfolio, ranked #4784.

Israel Englander first reported a position in VIR in Q2 2020 and has held it in 23 quarters since. The position peaked at $122M in Q1 2022. 236 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Israel Englander held 47,993 shares of Vir Biotechnology worth $489K as of Q2 2026.
  • Israel Englander sold 441,367 Vir Biotechnology shares in Q2 2026, an estimated $4.2M.
  • Vir Biotechnology made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4784 holding.
  • Israel Englander first reported a position in Vir Biotechnology in Q2 2020 and has held it in 23 quarters since.
  • Israel Englander's Vir Biotechnology position peaked at $122M in Q1 2022.
  • 236 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.